MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN) has a 88-report earnings history dating back to Nov 09, 2004. Its average absolute post-earnings move is ±10.35%, and 46.6% of those reactions were positive. Its largest post-earnings gain was +46.51% (Aug 05, 2025) and its largest decline was -46.6% (Jul 30, 2026). The next earnings report is predicted for 2026-11-05 (approximate).
Earnings reactions
How MYGN moved on each past earnings report.
Earnings Impact
Total Earnings
88
Avg Abs. Movement
±10.35%
Positive %
46.6%
Negative %
53.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 30, 2026 | ☽ POST | -46.6% | open_in_new |
| May 05, 2026 | ☽ POST | -18.15% | open_in_new |
| Feb 23, 2026 | ☽ POST | +1.14% | open_in_new |
| Nov 03, 2025 | ☽ POST | -21.03% | open_in_new |
Earnings Count
88
Total earnings in dataset
Avg Abs. Movement
±10.35%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260731 | open_in_new SEC.gov |
| 8-K | 20260730 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 8-K | 20260623 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 144 | 20260608 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
Frequently asked about MYGN earnings
When does MYRIAD GENETICS INC report earnings next? expand_more
MYRIAD GENETICS INC (MYGN)'s next earnings date is approximate for 2026-11-05. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MYGN stock move after earnings? expand_more
Over 88 reports, MYGN has moved an average of ±10.35% the session after earnings, closing higher 46.6% of the time.
What was MYGN's biggest post-earnings move? expand_more
MYGN's largest post-earnings gain on record was +46.51% on Aug 05, 2025, and its largest decline was -46.6% on Jul 30, 2026.
Where can I find MYRIAD GENETICS INC's SEC filings? expand_more
All of MYRIAD GENETICS INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right